Pre-S2 deletions of hepatitis B virus and hepatocellular carcinoma in children

Pediatric Research

Volumn 67, Issue 1, 2010, Pages 90-94

  Huang, Hsiang Po ^a   Hsu, Hong Yuan ^b   Chen, Chi Ling ^b   Ni, Yen Hsuan ^b   Wang, Hurng Yi ^b   Tsuei, Daw Jen ^b   Chiang, Cheng Lun ^b   Tsai, Yi Chen ^a   Chen, Huey Ling ^b   Chang, Mei Hwei ^b  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE DELETION; GENE SEQUENCE; GENOTYPE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; LIVER CELL CARCINOMA; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RISK FACTOR; SCHOOL CHILD;

ADOLESCENT; BASE SEQUENCE; CARCINOMA, HEPATOCELLULAR; CHILD; DNA PRIMERS; FEMALE; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; HUMANS; LIVER NEOPLASMS; MALE; POLYMERASE CHAIN REACTION; PROTEIN PRECURSORS; RISK FACTORS;

EID: 73449131849     PISSN: 00313998     EISSN: 15300447     Source Type: Journal    
DOI: 10.1203/PDR.0b013e3181c1b0b7     Document Type: Article

References (34)

1. Beasley RP, Hwang LY, Lin CC, Chien CS 1981 Hepatocellular carcinoma and hepatitis B virus. A prospective study of 22 707 men in Taiwan. Lancet 2:1129-1133
2. Hsu HC, Wu MZ, Chang MH, Su IJ, Chen DS 1987 Childhood hepatocellular carcinoma develops exclusively in hepatitis B surface antigen carriers in three decades in Taiwan. Report of 51 cases strongly associated with rapid development of liver cirrhosis. J Hepatol 5:260-267
3. Chang MH, Hsu HY, Ni YH, Tsai KS, Lee PI, Chen PJ, Hsu YL, Chen DS 1998 Precore stop codon mutant in chronic hepatitis B virus infection in children: its relation to hepatitis B e seroconversion and maternal hepatitis B surface antigen. J Hepatol 28:915-922
4. Ni YH, Chang MH, Wang KJ, Hsu HY, Chen HL, Kao JH, Yeh SH, Jeng YM, Tsai KS, Chen DS 2004 Clinical relevance of hepatitis B virus genotype in children with chronic infection and hepatocellular carcinoma. Gastroenterology 127:1733-1738
5. Ni YH, Chang MH, Hsu HY, Tsuei DJ 2004 Longitudinal study on mutation profiles of core promoter and precore regions of the hepatitis B virus genome in children. Pediatr Res 56:396-399
6. Ni YH, Chang MH, Hsu HY, Tsuei DJ 2003 Different hepatitis B virus core gene mutations in children with chronic infection and hepatocellular carcinoma. Gut 52:122-125
7. Naoumov NV, Schneider R, Grotzinger T, Jung MC, Miska S, Pape GR, Will H 1992 Precore mutant hepatitis B virus infection and liver disease. Gastroenterology 102:538-543
8. Kao JH, Chen PJ, Lai MY, Chen DS 2003 Basal core promoter mutations of hepatitis B virus increase the risk of hepatocellular carcinoma in hepatitis B carriers. Gastroenterology 124:327-334
9. Bruix J, Sherman M 2005 Management of hepatocellular carcinoma. Hepatology 42:1208-1236
10. Yeh SH, Tsai CY, Kao JH, Liu CJ, Kuo TJ, Lin MW, Huang WL, Lu SF, Jih J, Chen DS, Chen PJ 2004 Quantification and genotyping of hepatitis B virus in a single reaction by real-time PCR and melting curve analysis. J Hepatol 41:659-666
11. Chen BF, Liu CJ, Jow GM, Chen PJ, Kao JH, Chen DS 2006 Evolution of Hepatitis B virus in an acute hepatitis B patient co-infected with genotypes B and C. J Gen Virol 87:39-49
12. Kwok S, Higuchi R 1989 Avoiding false positives with PCR. Nature 339:237-238
13. Thompson JD, Higgins DG, Gibson TJ 1994 CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res 22:4673-4680
14. Rice P, Longden I, Bleasby A 2000 EMBOSS: the European Molecular Biology Open Software Suite. Trends Genet 16:276-277
15. Pollicino T, Zanetti AR, Cacciola I, Petit MA, Smedile A, Campo S, Sagliocca L, Pasquali M, Tanzi E, Longo G, Raimondo G 1997 Pre-S2 defective hepatitis B virus infection in patients with fulminant hepatitis. Hepatology 26:495-499
16. Fan YF, Lu CC, Chen WC, Yao WJ, Wang HC, Chang TT, Lei HY, Shiau AL, Su IJ 2001 Prevalence and significance of hepatitis B virus (HBV) pre-S mutants in serum and liver at different replicative stages of chronic HBV infection. Hepatology 33:277-286
17. Huy TT, Ushijima H, Win KM, Luengrojanakul P, Shrestha PK, Zhong ZH, Smirnov AV, Taltavull TC, Sata T, Abe K 2003 High prevalence of hepatitis B virus pre-s mutant in countries where it is endemic and its relationship with genotype and chronicity. J Clin Microbiol 41:5449-5455
18. Sugauchi F, Ohno T, Orito E, Sakugawa H, Ichida T, Komatsu M, Kuramitsu T, Ueda R, Miyakawa Y, Mizokami M 2003 Influence of hepatitis B virus genotypes on the development of preS deletions and advanced liver disease. J Med Virol 70:537-544
19. Choi MS, Kim DY, Lee DH, Lee JH, Koh KC, Paik SW, Rhee JC, Yoo BC 2007 Clinical significance of pre-S mutations in patients with genotype C hepatitis B virus infection. J Viral Hepat 14:161-168
20. Fang ZL, Sabin CA, Dong BQ, Wei SC, Chen QY, Fang KX, Yang JY, Huang J, Wang XY, Harrison TJ 2008 Hepatitis B virus pre-S deletion mutations are a risk factor for hepatocellular carcinoma: a matched nested case-control study. J Gen Virol 89:2882-2890
21. Chen CH, Changchien CS, Lee CM, Hung CH, Hu TH, Wang JH, Wang JC, Lu SN 2008 Combined mutations in pre-s/surface and core promoter/precore regions of hepatitis B virus increase the risk of hepatocellular carcinoma: a case-control study. J Infect Dis 198:1634-1642
22. Chen BF, Liu CJ, Jow GM, Chen PJ, Kao JH, Chen DS 2006 High prevalence and mapping of pre-S deletion in hepatitis B virus carriers with progressive liver diseases. Gastroenterology 130:1153-1168
23. Milich DR, Thornton GB, Neurath AR, Kent SB, Michel ML, Tiollais P, Chisari FV 1985 Enhanced immunogenicity of the pre-S region of hepatitis B surface antigen. Science 228:1195-1199
24. Milich DR, McLachlan A, Chisari FV, Thornton GB 1986 Nonoverlapping T and B cell determinants on an hepatitis B surface antigen pre-S(2) region synthetic peptide. J Exp Med 164:532-547
25. Bruss V, Vieluf K 1995 Functions of the internal pre-S domain of the large surface protein in hepatitis B virus particle morphogenesis. J Virol 69:6652-6657
26. Hildt E, Urban S, Hofschneider PH 1995 Characterization of essential domains for the functionality of the MHBst transcriptional activator and identification of a minimal MHBst activator. Oncogene 11:2055-2066
27. Kim HS, Ryu CJ, Hong HJ 1997 Hepatitis B virus preS1 functions as a transcrip-tional activation domain. J Gen Virol 78:1083-1086
28. Poisson F, Severac A, Hourioux C, Goudeau A, Roingeard P 1997 Both pre-S1 and S domains of hepatitis B virus envelope proteins interact with the core particle. Virology 228:115-120
29. Le Seyec J, Chouteau P, Cannie I, Guguen-Guillouzo C, Gripon P 1998 Role of the pre-S2 domain of the large envelope protein in hepatitis B virus assembly and infectivity. J Virol 72:5573-5578
30. Bock CT, Kubicka S, Manns MP, Trautwein C 1999 Two control elements in the hepatitis B virus S-promoter are important for full promoter activity mediated by CCAAT-binding factor. Hepatology 29:1236-1247
31. Sobotta D, Sominskaya I, Jansons J, Meisel H, Schmitt S, Heermann KH, Kaluza G, Pumpens P, Gerlich WH 2000 Mapping of immunodominant B-cell epitopes and the human serum albumin-binding site in natural hepatitis B virus surface antigen of defined genosubtype. J Gen Virol 81:369-378
32. Hsieh YH, Su IJ, Wang HC, Chang WW, Lei HY, Lai MD, Chang WT, Huang W 2004 Pre-S mutant surface antigens in chronic hepatitis B virus infection induce oxidative stress and DNA damage. Carcinogenesis 25:2023-2032
33. Wang HC, Huang W, Lai MD, Su IJ 2006 Hepatitis B virus pre-S mutants, endoplasmic reticulum stress and hepatocarcinogenesis. Cancer Sci 97:683-688
34. Lin CL, Liu CH, Chen W, Huang WL, Chen PJ, Lai MY, Chen DS, Kao JH 2007 Association of pre-S deletion mutant of hepatitis B virus with risk of hepatocellular carcinoma. J Gastroenterol Hepatol 22:1098-1103